NURS 6015 LATEST QUESTIONS AND ANSWERS. Buy Quality Materials! MODULE 9: HEMATOLOGICAL SYSTEM DRUGS Drugs for Anemia Drugs for Bleeding Disorders Drugs for Hematopoiesis Reversal Agents Ferrous Sulfate (Feosol) Anemia Classification: Iron preparation.

NURS 6015 LATEST QUESTIONS AND ANSWERS. Buy Quality Materials! MODULE 9: HEMATOLOGICAL SYSTEM DRUGS Drugs for Anemia Drugs for Bleeding Disorders Drugs for Hematopoiesis Reversal Agents Ferrous Sulfate (Feosol) Anemia Classification: Iron preparation. Mechanism of Action: Replenishes body iron stores needed for hemoglobin and myoglobin production, improving oxygen transport and preventing anemia. Therapeutic Use: Treats irondeficiency anemia. Medication Administration: Oral tablets, capsules, or liquid. Contraindications/Precautions: Avoid in individuals with hemochromatosis, hemosiderosis, or hemolytic anemia. Use cautiously in patients with GI conditions like ulcers or inflammatory bowel disease. Adverse Effects: Common: Nausea, constipation, dark stools, abdominal discomfort. Serious: GI bleeding, anaphylaxis (rare with oral formulations) . Patient Education: Take on an empty stomach for better absorption, with vitamin C (like orange juice) to enhance absorption. Avoid taking with calciumrich foods or antacids. Increase fluid and fiber intake to prevent constipation. Effectiveness: Hemoglobin levels improve; fatigue and other anemia symptoms decrease. Cyanocobalamin (Nascobal) Anemia Classification: Vitamin B12 supplement. Mechanism of Action: Replenishes B12, essential for DNA synthesis, red blood cell production, and neurologic function. Therapeutic Use: Treats B12 deficiency and pernicious anemia. Medication Administration: Oral, intramuscular (IM), subcutaneous, or nasal spray. Contraindications/Precautions: Avoid in patients with cobalt sensitivity or Leber’s optic atrophy. Use cautiously in megaloblastic anemia of unknown cause. Adverse Effects: Common: Injection site pain, headache, dizziness. Serious: Hypokalemia, anaphylaxis (rare). Patient Education: If using the nasal spray, avoid eating or drinking hot foods/beverages 1 hour before and after. For injections, periodic blood tests may be needed to monitor levels. Effectiveness: Improved energy levels, reduced anemia symptoms, and normalized B12 lab levels. Folic Acid Anemia Classification: Vitamin supplement. Mechanism of Action: Essential for DNA synthesis and red blood cell production. Therapeutic Use: Prevents and treats folate deficiency anemia; used in pregnancy to prevent neural tube defects. Medication Administration: Oral tablets, capsules, or injectable. Contraindications/Precautions: Avoid in untreated vitamin B12 deficiency (may mask symptoms). Adverse Effects: Common: Rare with appropriate dosing; nausea or rash possible. Serious: Allergic reactions (very rare). Patient Education: Take as prescribed, especially during pregnancy. Foods high in folate include leafy greens, citrus fruits, and beans. Effectiveness: Improved symptoms of anemia and normalized lab values. Heparin Bleeding Disorders Classification: Factor Xa/Thrombin inhibitor. Mechanism of Action: Activates antithrombin, which inhibits thrombin and factor Xa, preventing clot formation. Therapeutic Use: Prophylaxis and treatment of thromboembolic disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Medication Administration: Subcutaneous or intravenous (IV) injection. Contraindications/Precautions: Avoid in patients with active bleeding, severe thrombocytopenia, or a history of heparin induced thrombocytopenia (HIT). Adverse Effects: Common: Bleeding, bruising, pain at injection site. Serious: HIT, severe bleeding. Patient Education: Monitor for signs of bleeding (e.g., gums, stool) and report them. Avoid activities that increase bleeding risk. Effectiveness: Prevention of new clots or worsening of existing clots. Enoxaparin (Lovenox) Bleeding Disorders Classification: Low molecular weight heparin (LMWH). Mechanism of Action: Inhibits factor Xa to prevent clot formation. Therapeutic Use: Prevents and treats DVT and PE; used after surgeries to prevent clot formation. Medication Administration: Subcutaneous injection. Contraindications/Precautions: Avoid in active bleeding or history of HIT. Use cautiously in renal impairment and elderly. Adverse Effects: Common: Injection site bruising, mild bleeding. Serious: HIT, severe bleeding. Patient Education: Rotate injection sites to minimize bruising. Monitor for unusual bleeding or bruising. Avoid aspirin or NSAIDs unless approved by a provider. Effectiveness: Absence of new clots; stable anticoagulation.